Rapport Therapeutics presented at the TD Cowen summit, where upcoming bipolar disorder data were discussed.
At the TD Cowen summit, Rapport Therapeutics shared information regarding its bipolar disorder data. The company indicated that data are forthcoming. No further details were provided in the available source.
Further verified details were not immediately available.
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
More from Priya Anand →
